FR2696464B1
(fr)
*
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
|
FR2697522B1
(fr)
*
|
1992-10-30 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
FR2698361B1
(fr)
*
|
1992-11-20 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Procédé de préparation d'un acide oxazolidine-1,3 carboxylique-5.
|
MX9307777A
(es)
|
1992-12-15 |
1994-07-29 |
Upjohn Co |
7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
|
US5973160A
(en)
*
|
1992-12-23 |
1999-10-26 |
Poss; Michael A. |
Methods for the preparation of novel sidechain-bearing taxanes
|
EP0982301B1
(en)
*
|
1993-06-11 |
2003-09-10 |
PHARMACIA & UPJOHN COMPANY |
Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
|
FR2706457B1
(fr)
*
|
1993-06-16 |
1995-07-28 |
Rhone Poulenc Rorer Sa |
Procédé de préparation d'un acide oxazolidinecarboxylique utile pour préparer des taxoïdes thérapeutiquement actifs.
|
US6005120A
(en)
|
1993-07-20 |
1999-12-21 |
Florida State University |
Tricyclic and tetracyclic taxanes
|
EP0728130A1
(en)
*
|
1993-11-12 |
1996-08-28 |
PHARMACIA & UPJOHN COMPANY |
Pyrimidine-thioalkyl and alkylether compounds
|
IL127599A
(en)
*
|
1994-01-28 |
2004-06-01 |
Upjohn Co |
Process for preparing isotaxol analogs
|
US5679807A
(en)
*
|
1995-01-30 |
1997-10-21 |
Hauser, Inc. |
Preparation of taxol and docetaxel through primary amines
|
CA2170661A1
(en)
*
|
1995-03-22 |
1996-09-23 |
John K. Thottathil |
Novel methods for the preparation of taxanes using oaxzolidine intermediates
|
GB9512471D0
(en)
*
|
1995-06-20 |
1995-08-23 |
Pharmacia Spa |
Method for the preparation of taxol and its derivatives
|
US5688977A
(en)
*
|
1996-02-29 |
1997-11-18 |
Napro Biotherapeutics, Inc. |
Method for docetaxel synthesis
|
DE69731005T2
(de)
*
|
1996-05-08 |
2005-10-06 |
Pharmacia & Upjohn Co., Kalamazoo |
Verfahren zu Herstellung von Taxol
|
US7288665B1
(en)
|
1997-08-18 |
2007-10-30 |
Florida State University |
Process for selective derivatization of taxanes
|
ES2195378T3
(es)
|
1997-08-21 |
2003-12-01 |
Univ Florida State |
Procedimiento para la sintesis de taxanos.
|
WO1999032109A1
(en)
*
|
1997-12-23 |
1999-07-01 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
WO2002024179A2
(en)
|
2000-09-22 |
2002-03-28 |
Bristol-Myers Squibb Company |
Method for reducing toxicity of combined chemotherapies
|
US6891050B2
(en)
*
|
2001-08-10 |
2005-05-10 |
Dabur India Limited |
Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
|
US6881852B2
(en)
*
|
2002-02-05 |
2005-04-19 |
Dabur India Limited |
Process of purification of paclitaxel and docetaxel
|
US7247738B2
(en)
*
|
2002-05-07 |
2007-07-24 |
Dabur India Limited |
Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
|
US6900342B2
(en)
*
|
2002-05-10 |
2005-05-31 |
Dabur India Limited |
Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
DK1530465T4
(en)
|
2002-06-26 |
2016-03-21 |
Medigene Ag |
A method of producing a cationic liposomal preparation comprising a lipophilic compound.
|
JP2006513152A
(ja)
*
|
2002-10-09 |
2006-04-20 |
ファイトジェン ライフ サイエンシズ インコーポレイテッド |
新規タキサンならびにその使用および調製に関する方法
|
US6838569B2
(en)
|
2002-12-16 |
2005-01-04 |
Dabur India Limited |
Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
|
EP2390262A1
(en)
|
2003-05-16 |
2011-11-30 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
US7407973B2
(en)
*
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US7202370B2
(en)
*
|
2003-10-27 |
2007-04-10 |
Conor Medsystems, Inc. |
Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
|
KR20070085227A
(ko)
*
|
2004-08-09 |
2007-08-27 |
앨리오스 바이오파마 인크. |
합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
EP1712552A1
(en)
*
|
2005-04-11 |
2006-10-18 |
INDENA S.p.A. |
Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
|
US7446126B2
(en)
|
2004-10-08 |
2008-11-04 |
Indena S.P.A. |
Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
|
EP1647552A1
(en)
*
|
2004-10-08 |
2006-04-19 |
INDENA S.p.A. |
Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
|
WO2006089209A2
(en)
*
|
2005-02-17 |
2006-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
US20100160653A1
(en)
*
|
2006-03-21 |
2010-06-24 |
Dr. Reddy's Laboratories Ltd. |
Docetaxel polymorphs and processes
|
ES2609388T3
(es)
|
2006-03-22 |
2017-04-20 |
Syncore Biotechnology Co., Ltd |
Tratamiento del cáncer de mama triple negativo a receptores
|
ITMI20062479A1
(it)
*
|
2006-12-21 |
2008-06-22 |
Indena Spa |
Processo per la preparazione di secotassani
|
ATE520576T1
(de)
*
|
2007-05-30 |
2011-09-15 |
Mitsubishi Electric Corp |
Bremssteuerungsgerät für ein elektrisches fahrzeug
|
EP2859916B1
(en)
|
2008-05-22 |
2017-11-29 |
Galera Labs, LLC |
Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy
|
KR101003822B1
(ko)
|
2008-06-20 |
2010-12-27 |
주식회사 셀트리온화학연구소 |
도세탁셀의 제조방법 및 도세탁셀의 제조를 위한 신규한중간체
|
US20110172293A1
(en)
|
2008-07-08 |
2011-07-14 |
Fish Jason E |
Methods and Compositions for Modulating Angiogenesis
|
CN101735179B
(zh)
*
|
2008-11-19 |
2012-09-12 |
上海百灵医药科技有限公司 |
一种多烯紫杉醇的制备方法,其中间体及制备方法
|
WO2010059916A2
(en)
*
|
2008-11-20 |
2010-05-27 |
Dr. Reddy's Laboratories Ltd. |
Preparation of docetaxel
|
PL388144A1
(pl)
|
2009-05-29 |
2010-12-06 |
Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością |
Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
|
KR102165464B1
(ko)
|
2012-07-19 |
2020-10-14 |
레드우드 바이오사이언스 인코포레이티드 |
Cd22에 대해 특이적인 항체 및 이들의 사용 방법
|
CA2890190A1
(en)
|
2012-11-12 |
2014-05-15 |
Redwood Bioscience, Inc. |
Compounds and methods for producing a conjugate
|
PT3613439T
(pt)
|
2013-02-15 |
2021-05-12 |
Univ California |
Recetor de antigénio quimérico e métodos de utilização do mesmo
|
US9670162B2
(en)
|
2013-03-14 |
2017-06-06 |
The Board Of Trustees Of The Leland Stanford Junio |
Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
|
CN105744935B
(zh)
|
2013-11-27 |
2022-09-30 |
雷德伍德生物科技股份有限公司 |
肼基-吡咯并化合物及用于生成缀合物的方法
|
ES2833157T3
(es)
|
2014-02-19 |
2021-06-14 |
Aviv Therapeutics Inc |
Amidas políciclicas de unión a aldehído deshidrogenasa 2 mitocondrial (aldh2) y su uso para el tratamiento del cáncer
|
KR20220123560A
(ko)
|
2014-03-21 |
2022-09-07 |
애브비 인코포레이티드 |
항-egfr 항체 및 항체 약물 접합체
|
WO2017083637A1
(en)
|
2015-11-12 |
2017-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
EP3231421A1
(en)
|
2016-04-11 |
2017-10-18 |
Greenaltech, S.L. |
Uses of a carotenoid in the treatment or prevention of stress induced conditions
|
WO2017189432A1
(en)
|
2016-04-26 |
2017-11-02 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
ES2905874T3
(es)
|
2016-06-01 |
2022-04-12 |
Servier Ip Uk Ltd |
Formulaciones de óxido de polialquileno-asparaginasa y métodos para elaborar y usar las mismas
|
UA124198C2
(uk)
|
2016-06-08 |
2021-08-04 |
Еббві Інк. |
Кон'югат антитіла до в7-н3 та лікарського засобу
|
US20200338209A1
(en)
|
2016-06-08 |
2020-10-29 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
WO2017214458A2
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
EP3468598A1
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
US20200002421A1
(en)
|
2016-06-08 |
2020-01-02 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
TW201825087A
(zh)
|
2017-01-05 |
2018-07-16 |
杏國新藥股份有限公司 |
胰臟癌治療
|
KR20190130559A
(ko)
|
2017-01-18 |
2019-11-22 |
에프1 온콜로지, 인코포레이티드 |
Axl 또는 ror2에 대한 키메라 항원 수용체 및 이의 사용 방법
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
AU2019215032A1
(en)
|
2018-01-31 |
2020-09-10 |
Board Of Regents Of The University Of Texas System |
Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
JP2021521173A
(ja)
|
2018-04-11 |
2021-08-26 |
オハイオ・ステイト・イノベーション・ファウンデーション |
眼内薬物送達用の持続放出微粒子のための方法及び組成物
|
US11897928B2
(en)
|
2018-07-18 |
2024-02-13 |
Manzanita Pharmaceuticals, Inc. |
Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
|
JP2022527860A
(ja)
|
2019-04-02 |
2022-06-06 |
ケンジョッケティ バイオテクノロジー,インク. |
排出ポンプ-癌抗原マルチ特異性抗体ならびにそれに関する組成物、試薬、キットおよび方法
|
US20230203156A1
(en)
|
2020-01-29 |
2023-06-29 |
Kenjockety Biotechnology, Inc. |
Anti-mdr1 antibodies and uses thereof
|
AU2021283080A1
(en)
|
2020-06-04 |
2022-12-15 |
Kenjockety Biotechnology, Inc. |
ABCG2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
JP2023528416A
(ja)
|
2020-06-04 |
2023-07-04 |
ケンジョッケティ バイオテクノロジー,インク. |
抗abcg2抗体及びそれらの使用
|
US20230272117A1
(en)
|
2020-09-02 |
2023-08-31 |
Kenjockety Biotechnology, Inc. |
Anti abcc1 antibodies and uses thereof
|
CA3203652A1
(en)
|
2020-11-13 |
2022-05-19 |
William Robert ARATHOON |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
KR20240116829A
(ko)
|
2021-12-13 |
2024-07-30 |
윌리엄 로버트 아라툰 리빙 트러스트 데이티드 어거스트 29, 2016 |
항-abcb1 항체
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|